Review of Clinical Trial Access Quality Performance Indicator

Closes 18 Aug 2017

Opened 3 Jul 2017


Under the auspices of the Scottish Cancer Taskforce, National Cancer Quality Performance Indicators (QPIs) were developed to drive continuous quality improvement in cancer care across NHSScotland.  In July 2014, the Clinical Trial Access QPI was published, and following 3 years of national comparative data, this has now been subject to formal review.  In order to ensure success of the National Cancer QPIs in driving quality improvement it is critical that QPIs continue to be clinically relevant and focus on areas which will result in improvements to the quality of patient care.  

Your browser does not support inline PDF viewing.Please download the PDF.

Download the full consultation paper.

View accessible HTML version


Why We Are Consulting

Wide clinical and public engagement is crucial to ensure wide inclusiveness of clinical colleagues across NHSScotland.  It is also vital to include the patients and the public as key stakeholders in this consultation to ensure the acceptability of the QPIs.  We would like your comments on the Revised Clinical Trial Access QPI.  In particular we would like to hear your views on:

  • The appropriateness of the QPI that has been developed.
  • The target level that has been set.
  • Key points or areas that are not covered within the QPI
  • Feasibility of measuring the QPI identified in a meaningful and comparative way (i.e. ‘like for like’ comparison)

A form to assist with submission of comments has been developed and should be used wherever possible.  Please note that supporting evidence should be detailed along with comments where appropriate.

Give Us Your Views


  • All Areas


  • People of Scotland


  • Health and Social Care